首页 | 官方网站   微博 | 高级检索  
     


Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re-11, Re-12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickens
Authors:ZENG Xian-ying  CHEN Xiao-han  MA Shu-jie  WU Jiao-jiao  BAO Hong-mei  PAN Shu-xin  LIU Yan-jing  DENG Guo-hua  SHI Jian-zhong  CHEN Pu-cheng  JIANG Yong-ping  LI Yan-bing  HU Jing-lei  LU Tong  MAO Sheng-gang  GUO Xing-fu  LIU Jing-li  TIAN Guo-bin  CHEN Hua-lan
Affiliation:1 State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, P.R.China 2 Harbin Weike Biotechnology Development Company, Harbin 150069, P.R.China 
Abstract:We developed an H5/H7 trivalent inactivated vaccine by using Re-11, Re-12, and H7-Re2 vaccine seed viruses, which were generated by reverse genetics and derived their HA genes from A/duck/Guizhou/S4184/2017(H5N6) (DK/GZ/S4184/17) (a clade 2.3.4.4d virus), A/chicken/Liaoning/SD007/2017(H5N1) (CK/LN/SD007/17) (a clade 2.3.2.1d virus), and A/chicken/Guangxi/SD098/2017(H7N9) (CK/GX/SD098/17), respectively. The protective efficacy of this novel vaccine and that of the recently used H5/H7 bivalent inactivated vaccine against different H5 and H7N9 viruses was evaluated in chickens. We found that the H5/H7 bivalent vaccine provided solid protection against the H7N9 virus CK/GX/SD098/17, but only 50–60% protection against different H5 viruses. In contrast, the novel H5/H7 trivalent vaccine provided complete protection against the H5 and H7 viruses tested. Our study underscores the importance of timely updating of vaccines for avian influenza control.
Keywords:avian influenza  H5/H7 trivalent vaccine  Re-11  Re-12 and H7-Re2 strains  protective efficacy
本文献已被 CNKI ScienceDirect 等数据库收录!
点击此处可从《农业科学学报(英文版)》浏览原始摘要信息
点击此处可从《农业科学学报(英文版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号